DongKoo Bio & Pharma Revenue

In the year 2025, DongKoo Bio & Pharma had annual revenue of 242.69B KRW, down -2.64%. DongKoo Bio & Pharma had revenue of 61.87B in the quarter ending December 31, 2025, with 7.47% growth.

Revenue

242.69B

Revenue Growth

-2.64%

P/S Ratio

0.58

Revenue / Employee

600.71M

Employees

404

Market Cap

139.81B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	242.69B	-6.59B	-2.64%
Dec 31, 2024	249.27B	33.59B	15.57%
Dec 31, 2023	215.69B	20.70B	10.62%
Dec 31, 2022	194.99B	39.84B	25.68%
Dec 31, 2021	155.15B	15.93B	11.45%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PHARMARESEARCH BIO	178.19M
HYUNDAI BIOLAND	130.51B
Kyung Dong Pharmaceutical	196.27B
KOREA PHARMA	87.60B
Organoidsciences	2.41B
WITHUS PHARMACEUTICAL Co.,LTD.	106.44B
OPTUS Pharmaceutical	87.16B
H.PIO	258.19B

Revenue Rankings